Bayesian Capital Management, LP
- SEC CIK
- 0001632551
- Latest filing
- Aug 14, 2026
OCUL holding history
Ocular Therapeutix, Inc in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −11,900−100.0% | Sold out | Holders |
| Q1 2026 | 11,900 | $100.8K | 0.1% | +11,900 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −17,000−100.0% | Sold out | Holders |
| Q1 2025 | 17,000 | $124.6K | <0.1% | +17,000 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −10,304−100.0% | Sold out | Holders |
| Q1 2024 | 10,304 | $93.8K | <0.1% | +10,304 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −37,400−100.0% | Sold out | Holders |
| Q2 2023 | 37,400 | $193.0K | <0.1% | +37,400 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −16,200−100.0% | Sold out | Holders |
| Q2 2022 | 16,200 | $65.0K | <0.1% | +2,200+15.7% | Added | Holders |
| Q1 2022 | 14,000 | $69.0K | <0.1% | +14,000 | New | Holders |